GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Interest Income

Amicogen (XKRX:092040) Interest Income : ₩534 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Amicogen's interest income for the three months ended in Dec. 2024 was ₩144 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was ₩534 Mil.

Amicogen Interest Income Historical Data

The historical data trend for Amicogen's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Interest Income Chart

Amicogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 261.53 349.29 412.85 498.38 533.63

Amicogen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 118.82 109.00 185.98 95.00 143.65

Amicogen Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩534 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amicogen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Interest Income
Comparable Companies
XKRX:001630 XKRX:096760 XKRX:102460 XKRX:476060 XKRX:293780 XKRX:007570 XKRX:005500 XKRX:271980 XKRX:293480 XKRX:016580 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Website
http://www.amicogen.com
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.

Amicogen Headlines

No Headlines